Home / Pharmaceutical / Merger and Acquisition Deals and Alliances of 2014

Merger and Acquisition Deals and Alliances of 2014

Published: Mar 2015 | No Of Pages: 200 | Published By: Current Partnering
The Merger and Acquisition Deals of 2014 provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare companies during 2014.
 
Using these reports, dealmakers will effectively and efficiently gain insight into the M&A activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
 
The initial chapters of this report provide an orientation of 2014’s M&A dealmaking and business activities.
 
Chapter 1 provides an overview of the trends in M&A dealmaking during 2014.
 
Chapter 2 provides a review of the leading M&A deals during 2014. Deals are listed by headline value, signed by big pharma and big biotech, and most active biopharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
 
Chapter 3 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of 2014 M&A deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
 
Chapter 4 provides a comprehensive directory of all M&A deals announced during 2014. 
 
The chapter is organized by company A-Z. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
 
The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma M&A dealmaking during 2014.
 
In conclusion, this report provides everything a prospective M&A dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
Executive Summary
 
Chapter 1 – Trends in M&A dealmaking during 2014
1.1. Dealmaking activity by month
1.2. M&A by therapy area
1.3. M&A by industry sector
 
Chapter 2 – Leading M&A deals during 2014
2.1. Introduction
2.2. Top deals by value during 2014
2.3 Most active M&A dealmakers during 2014
 
Chapter 3 – Big pharma M&A deals during 2014
3.1. Introduction
3.2. How to use big pharma M&A deals
3.3. Big pharma M&A company profiles for 2014
Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson
 
Chapter 4 – M&A deals directory 2014
4.1. Introduction
4.2. Company A-Z
About Wildwood Ventures
Current Partnering
Current Agreements
Current Reports
Recent titles from CurrentPartnering
Order Form – Reports

 

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +